New Experimental Therapeutics of San Antonio-NEXT Oncology

San Antonio, Texas 78240

1 studies enrolling now · 7 studies all time

What they study most

Advanced Malignant Neoplasm, Advanced Solid Tumor, Breast Cancer, Colorectal Cancer, ER/PR Positive Breast Cancer, ER/PR(+), Her2(-) Breast Cancer, Endometrial Adenocarcinoma, Endometrial Cancer, Endometrial Cancer Recurrent, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Diseases

Studies at this site

• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) — Recruiting now
• A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies — Running, not enrolling
• A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors — Stopped early
• Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer — Stopped early
• A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) — Stopped early
• Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies — Status unconfirmed
• Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer — Completed